ID PUR1_BACSU Reviewed; 476 AA. AC P00497; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 07-JUL-2009, sequence version 2. DT 27-MAR-2024, entry version 185. DE RecName: Full=Amidophosphoribosyltransferase {ECO:0000255|HAMAP-Rule:MF_01931}; DE Short=ATase {ECO:0000255|HAMAP-Rule:MF_01931}; DE EC=2.4.2.14 {ECO:0000255|HAMAP-Rule:MF_01931, ECO:0000269|PubMed:6794613}; DE AltName: Full=Glutamine phosphoribosylpyrophosphate amidotransferase {ECO:0000255|HAMAP-Rule:MF_01931}; DE Short=GPATase {ECO:0000255|HAMAP-Rule:MF_01931}; DE Flags: Precursor; GN Name=purF {ECO:0000255|HAMAP-Rule:MF_01931, GN ECO:0000303|PubMed:6411717}; OrderedLocusNames=BSU06490; OS Bacillus subtilis (strain 168). OC Bacteria; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus. OX NCBI_TaxID=224308; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=6411717; DOI=10.1016/s0021-9258(17)44497-8; RA Makaroff C.A., Zalkin H., Switzer R.L., Vollmer S.J.; RT "Cloning of the Bacillus subtilis glutamine phosphoribosylpyrophosphate RT amidotransferase gene in Escherichia coli. Nucleotide sequence RT determination and properties of the plasmid-encoded enzyme."; RL J. Biol. Chem. 258:10586-10593(1983). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3036807; DOI=10.1016/s0021-9258(18)47560-6; RA Ebbole D.J., Zalkin H.; RT "Cloning and characterization of a 12-gene cluster from Bacillus subtilis RT encoding nine enzymes for de novo purine nucleotide synthesis."; RL J. Biol. Chem. 262:8274-8287(1987). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=168; RX PubMed=9384377; DOI=10.1038/36786; RA Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V., RA Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R., RA Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S., RA Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K., RA Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F., RA Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D., RA Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M., RA Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P., RA Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K., RA Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S., RA Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y., RA Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G., RA Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J., RA Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C., RA Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S., RA Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B., RA Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S., RA Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M., RA Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y., RA Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J., RA Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A., RA Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M., RA Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S., RA Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E., RA Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K., RA Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E., RA Yoshikawa H., Danchin A.; RT "The complete genome sequence of the Gram-positive bacterium Bacillus RT subtilis."; RL Nature 390:249-256(1997). RN [4] RP SEQUENCE REVISION TO 413. RX PubMed=19383706; DOI=10.1099/mic.0.027839-0; RA Barbe V., Cruveiller S., Kunst F., Lenoble P., Meurice G., Sekowska A., RA Vallenet D., Wang T., Moszer I., Medigue C., Danchin A.; RT "From a consortium sequence to a unified sequence: the Bacillus subtilis RT 168 reference genome a decade later."; RL Microbiology 155:1758-1775(2009). RN [5] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=6794613; DOI=10.1021/bi00523a005; RA Wong J.Y., Bernlohr D.A., Turnbough C.L., Switzer R.L.; RT "Purification and properties of glutamine phosphoribosylpyrophosphate RT amidotransferase from Bacillus subtilis."; RL Biochemistry 20:5669-5674(1981). RN [6] RP ACTIVE SITE, AND PROTEIN SEQUENCE OF 12-35. RX PubMed=6411716; DOI=10.1016/s0021-9258(17)44496-6; RA Vollmer S.J., Switzer R.L., Hermodson M.A., Bower S.G., Zalkin H.; RT "The glutamine-utilizing site of Bacillus subtilis glutamine RT phosphoribosylpyrophosphate amidotransferase."; RL J. Biol. Chem. 258:10582-10585(1983). RN [7] RP MUTAGENESIS OF CYS-12. RX PubMed=6094545; DOI=10.1016/s0021-9258(18)89882-9; RA Maentsaelae P., Zalkin H.; RT "Glutamine amidotransferase function. Replacement of the active-site RT cysteine in glutamine phosphoribosylpyrophosphate amidotransferase by site- RT directed mutagenesis."; RL J. Biol. Chem. 259:14230-14236(1984). RN [8] RP MUTAGENESIS. RX PubMed=3090047; DOI=10.1016/s0021-9258(18)67401-0; RA Makaroff C.A., Paluh J.L., Zalkin H.; RT "Mutagenesis of ligands to the [4 Fe-4S] center of Bacillus subtilis RT glutamine phosphoribosylpyrophosphate amidotransferase."; RL J. Biol. Chem. 261:11416-11423(1986). RN [9] RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH IRON-SULFUR (4FE-4S), RP ACTIVITY REGULATION, AND SUBUNIT. RX PubMed=8197456; DOI=10.1126/science.8197456; RA Smith J.L., Zaluzec E.J., Wery J.-P., Niu L., Switzer R.L., Zalkin H., RA Satow Y.; RT "Structure of the allosteric regulatory enzyme of purine biosynthesis."; RL Science 264:1427-1433(1994). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH IRON-SULFUR (4FE-4S) RP AND MAGNESIUM. RX PubMed=9271502; DOI=10.1021/bi9711893; RA Chen S., Tomchick D.R., Wolle D., Hu P., Smith J.L., Switzer R.L., RA Zalkin H.; RT "Mechanism of the synergistic end-product regulation of Bacillus subtilis RT glutamine phosphoribosylpyrophosphate amidotransferase by nucleotides."; RL Biochemistry 36:10718-10726(1997). CC -!- FUNCTION: Catalyzes the formation of phosphoribosylamine from CC phosphoribosylpyrophosphate (PRPP) and glutamine. {ECO:0000255|HAMAP- CC Rule:MF_01931, ECO:0000269|PubMed:6794613}. CC -!- CATALYTIC ACTIVITY: CC Reaction=5-phospho-beta-D-ribosylamine + diphosphate + L-glutamate = 5- CC phospho-alpha-D-ribose 1-diphosphate + H2O + L-glutamine; CC Xref=Rhea:RHEA:14905, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:58017, ChEBI:CHEBI:58359, CC ChEBI:CHEBI:58681; EC=2.4.2.14; Evidence={ECO:0000255|HAMAP- CC Rule:MF_01931, ECO:0000269|PubMed:6794613}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP- CC Rule:MF_01931, ECO:0000269|PubMed:9271502}; CC Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000255|HAMAP-Rule:MF_01931, CC ECO:0000269|PubMed:9271502}; CC -!- COFACTOR: CC Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; CC Evidence={ECO:0000269|PubMed:8197456}; CC Note=Binds 1 [4Fe-4S] cluster per subunit. The [4Fe-4S] cluster CC requires a potential lower than -600 mV for reduction. CC {ECO:0000269|PubMed:8197456}; CC -!- ACTIVITY REGULATION: Allosterically regulated; subject to end product CC regulation by purine nucleotides. {ECO:0000269|PubMed:8197456}. CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; N(1)- CC (5-phospho-D-ribosyl)glycinamide from 5-phospho-alpha-D-ribose 1- CC diphosphate: step 1/2. {ECO:0000255|HAMAP-Rule:MF_01931}. CC -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:8197456}. CC -!- SIMILARITY: In the C-terminal section; belongs to the purine/pyrimidine CC phosphoribosyltransferase family. {ECO:0000255|HAMAP-Rule:MF_01931, CC ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J02732; AAA22680.1; -; Genomic_DNA. DR EMBL; AL009126; CAB12469.2; -; Genomic_DNA. DR PIR; A00582; XQBS. DR RefSeq; NP_388531.2; NC_000964.3. DR RefSeq; WP_003233947.1; NZ_JNCM01000032.1. DR PDB; 1AO0; X-ray; 2.80 A; A/B/C/D=12-470. DR PDB; 1GPH; X-ray; 3.00 A; 1/2/3/4=12-476. DR PDBsum; 1AO0; -. DR PDBsum; 1GPH; -. DR AlphaFoldDB; P00497; -. DR SMR; P00497; -. DR IntAct; P00497; 1. DR MINT; P00497; -. DR STRING; 224308.BSU06490; -. DR DrugBank; DB01972; Guanosine-5'-Monophosphate. DR MEROPS; C44.001; -. DR PaxDb; 224308-BSU06490; -. DR EnsemblBacteria; CAB12469; CAB12469; BSU_06490. DR GeneID; 83883911; -. DR GeneID; 936046; -. DR KEGG; bsu:BSU06490; -. DR PATRIC; fig|224308.179.peg.705; -. DR eggNOG; COG0034; Bacteria. DR InParanoid; P00497; -. DR OrthoDB; 9801213at2; -. DR PhylomeDB; P00497; -. DR BioCyc; BSUB:BSU06490-MONOMER; -. DR BRENDA; 2.4.2.14; 658. DR UniPathway; UPA00074; UER00124. DR EvolutionaryTrace; P00497; -. DR Proteomes; UP000001570; Chromosome. DR GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW. DR GO; GO:0004044; F:amidophosphoribosyltransferase activity; IBA:GO_Central. DR GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniRule. DR GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW. DR GO; GO:0009113; P:purine nucleobase biosynthetic process; IEA:InterPro. DR GO; GO:0006164; P:purine nucleotide biosynthetic process; IBA:GO_Central. DR CDD; cd00715; GPATase_N; 1. DR CDD; cd06223; PRTases_typeI; 1. DR Gene3D; 3.40.50.2020; -; 1. DR Gene3D; 3.60.20.10; Glutamine Phosphoribosylpyrophosphate, subunit 1, domain 1; 1. DR HAMAP; MF_01931; PurF; 1. DR InterPro; IPR017932; GATase_2_dom. DR InterPro; IPR029055; Ntn_hydrolases_N. DR InterPro; IPR000836; PRibTrfase_dom. DR InterPro; IPR029057; PRTase-like. DR InterPro; IPR005854; PurF. DR InterPro; IPR035584; PurF_N. DR NCBIfam; TIGR01134; purF; 1. DR PANTHER; PTHR11907; AMIDOPHOSPHORIBOSYLTRANSFERASE; 1. DR PANTHER; PTHR11907:SF0; AMIDOPHOSPHORIBOSYLTRANSFERASE; 1. DR Pfam; PF13522; GATase_6; 1. DR PIRSF; PIRSF000485; Amd_phspho_trans; 1. DR SUPFAM; SSF56235; N-terminal nucleophile aminohydrolases (Ntn hydrolases); 1. DR SUPFAM; SSF53271; PRTase-like; 1. DR PROSITE; PS51278; GATASE_TYPE_2; 1. DR PROSITE; PS00103; PUR_PYR_PR_TRANSFER; 1. PE 1: Evidence at protein level; KW 3D-structure; 4Fe-4S; Allosteric enzyme; Direct protein sequencing; KW Glutamine amidotransferase; Glycosyltransferase; Iron; Iron-sulfur; KW Magnesium; Metal-binding; Purine biosynthesis; Reference proteome; KW Transferase. FT PROPEP 1..11 FT /evidence="ECO:0000269|PubMed:6411716" FT /id="PRO_0000029251" FT CHAIN 12..476 FT /note="Amidophosphoribosyltransferase" FT /id="PRO_0000029252" FT DOMAIN 12..231 FT /note="Glutamine amidotransferase type-2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931" FT ACT_SITE 12 FT /note="Nucleophile" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:6411716" FT BINDING 247 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:8197456, ECO:0000269|PubMed:9271502" FT BINDING 294 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:9271502" FT BINDING 356 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:9271502" FT BINDING 357 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:9271502" FT BINDING 393 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:8197456, ECO:0000269|PubMed:9271502" FT BINDING 448 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:8197456, ECO:0000269|PubMed:9271502" FT BINDING 451 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01931, FT ECO:0000269|PubMed:8197456, ECO:0000269|PubMed:9271502" FT MUTAGEN 12 FT /note="C->F: Loss of enzyme activity and N-terminal FT processing." FT /evidence="ECO:0000269|PubMed:6094545" FT MUTAGEN 394 FT /note="F->V: Partial loss of activity." FT /evidence="ECO:0000269|PubMed:3090047" FT MUTAGEN 442 FT /note="D->S: Partial loss of activity." FT /evidence="ECO:0000269|PubMed:3090047" FT MUTAGEN 448 FT /note="C->S: Loss of activity." FT /evidence="ECO:0000269|PubMed:3090047" FT MUTAGEN 451 FT /note="C->S: Loss of activity." FT /evidence="ECO:0000269|PubMed:3090047" FT MUTAGEN 452 FT /note="F->C: Lethal." FT /evidence="ECO:0000269|PubMed:3090047" FT CONFLICT 413 FT /note="E -> G (in Ref. 1 and 2; AAA22680)" FT /evidence="ECO:0000305" FT STRAND 13..19 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 23..33 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 34..37 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 40..47 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 52..59 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 61..64 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 67..69 FT /evidence="ECO:0007829|PDB:1GPH" FT TURN 70..72 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 75..83 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 86..88 FT /evidence="ECO:0007829|PDB:1GPH" FT HELIX 92..94 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 95..101 FT /evidence="ECO:0007829|PDB:1AO0" FT TURN 103..105 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 108..116 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 119..128 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 133..135 FT /evidence="ECO:0007829|PDB:1GPH" FT HELIX 138..147 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 154..162 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 167..174 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 176..183 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 192..196 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 199..205 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 207..212 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 215..219 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 224..229 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 232..238 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 248..252 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 266..281 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 286..289 FT /evidence="ECO:0007829|PDB:1AO0" FT TURN 292..295 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 296..306 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 314..316 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 329..334 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 338..342 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 344..347 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 351..357 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 360..362 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 363..374 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 378..386 FT /evidence="ECO:0007829|PDB:1AO0" FT TURN 397..399 FT /evidence="ECO:0007829|PDB:1AO0" FT TURN 407..409 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 412..419 FT /evidence="ECO:0007829|PDB:1AO0" FT STRAND 422..426 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 429..436 FT /evidence="ECO:0007829|PDB:1AO0" FT TURN 443..446 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 450..453 FT /evidence="ECO:0007829|PDB:1AO0" FT HELIX 467..469 FT /evidence="ECO:0007829|PDB:1AO0" SQ SEQUENCE 476 AA; 51692 MW; 6BC2FDA3288002F0 CRC64; MLAEIKGLNE ECGVFGIWGH EEAPQITYYG LHSLQHRGQE GAGIVATDGE KLTAHKGQGL ITEVFQNGEL SKVKGKGAIG HVRYATAGGG GYENVQPLLF RSQNNGSLAL AHNGNLVNAT QLKQQLENQG SIFQTSSDTE VLAHLIKRSG HFTLKDQIKN SLSMLKGAYA FLIMTETEMI VALDPNGLRP LSIGMMGDAY VVASETCAFD VVGATYLREV EPGEMLIIND EGMKSERFSM NINRSICSME YIYFSRPDSN IDGINVHSAR KNLGKMLAQE SAVEADVVTG VPDSSISAAI GYAEATGIPY ELGLIKNRYV GRTFIQPSQA LREQGVRMKL SAVRGVVEGK RVVMVDDSIV RGTTSRRIVT MLREAGATEV HVKISSPPIA HPCFYGIDTS THEELIASSH SVEEIRQEIG ADTLSFLSVE GLLKGIGRKY DDSNCGQCLA CFTGKYPTEI YQDTVLPHVK EAVLTK //